172 related articles for article (PubMed ID: 27988463)
1. Thiazolidinediones and PPAR orchestra as antidiabetic agents: From past to present.
Yasmin S; Jayaprakash V
Eur J Med Chem; 2017 Jan; 126():879-893. PubMed ID: 27988463
[TBL] [Abstract][Full Text] [Related]
2. Thiazolidinediones as antidiabetic agents: A critical review.
Nanjan MJ; Mohammed M; Prashantha Kumar BR; Chandrasekar MJN
Bioorg Chem; 2018 Apr; 77():548-567. PubMed ID: 29475164
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARγ/FFAR1 dual agonists.
Darwish KM; Salama I; Mostafa S; Gomaa MS; Helal MA
Eur J Med Chem; 2016 Feb; 109():157-72. PubMed ID: 26774923
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
Naim MJ; Alam O; Alam MJ; Shaquiquzzaman M; Alam MM; Naidu VGM
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700223. PubMed ID: 29400412
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic journey of 2,4-thiazolidinediones as a versatile scaffold: An insight into structure activity relationship.
Naim MJ; Alam MJ; Ahmad S; Nawaz F; Shrivastava N; Sahu M; Alam O
Eur J Med Chem; 2017 Mar; 129():218-250. PubMed ID: 28231521
[TBL] [Abstract][Full Text] [Related]
6. Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents.
Sohda T; Mizuno K; Momose Y; Ikeda H; Fujita T; Meguro K
J Med Chem; 1992 Jul; 35(14):2617-26. PubMed ID: 1635060
[TBL] [Abstract][Full Text] [Related]
7. Identification of plant extracts with potential antidiabetic properties: effect on human peroxisome proliferator-activated receptor (PPAR), adipocyte differentiation and insulin-stimulated glucose uptake.
Christensen KB; Minet A; Svenstrup H; Grevsen K; Zhang H; Schrader E; Rimbach G; Wein S; Wolffram S; Kristiansen K; Christensen LP
Phytother Res; 2009 Sep; 23(9):1316-25. PubMed ID: 19172665
[TBL] [Abstract][Full Text] [Related]
8. A review on the development in the field of NIDDM based thiazolidinedione PPARγ agonists.
Banerjee PS; Samanta S
Mini Rev Med Chem; 2013 Apr; 13(5):706-12. PubMed ID: 22512587
[TBL] [Abstract][Full Text] [Related]
9. The roles of peroxisome proliferator-activated receptors in the metabolic syndrome.
Mansour M
Prog Mol Biol Transl Sci; 2014; 121():217-66. PubMed ID: 24373239
[TBL] [Abstract][Full Text] [Related]
10. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
Huang TH; Roufogalis BD
Curr Mol Pharmacol; 2012 Jun; 5(2):241-7. PubMed ID: 22122453
[TBL] [Abstract][Full Text] [Related]
11. Molecular design, synthesis, and hypoglycemic and hypolipidemic activities of novel pyrimidine derivatives having thiazolidinedione.
Lee HW; Kim BY; Ahn JB; Kang SK; Lee JH; Shin JS; Ahn SK; Lee SJ; Yoon SS
Eur J Med Chem; 2005 Sep; 40(9):862-74. PubMed ID: 15908051
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
[TBL] [Abstract][Full Text] [Related]
13. Dual PPAR-alpha and -gamma activators derived from novel benzoxazinone containing thiazolidinediones having antidiabetic and hypolipidemic potential.
Madhavan GR; Chakrabarti R; Reddy KA; Rajesh BM; Balraju V; Rao PB; Rajagopalan R; Iqbal J
Bioorg Med Chem; 2006 Jan; 14(2):584-91. PubMed ID: 16198573
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects].
Sugiyama Y; Murase K; Ikeda H
Nihon Rinsho; 2000 Feb; 58(2):370-5. PubMed ID: 10707560
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.
Ferruzzi P; Ceni E; Tarocchi M; Grappone C; Milani S; Galli A; Fiorelli G; Serio M; Mannelli M
J Clin Endocrinol Metab; 2005 Mar; 90(3):1332-9. PubMed ID: 15585569
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and PPAR insulin sensitizers.
Bhatia V; Viswanathan P
Curr Opin Investig Drugs; 2006 Oct; 7(10):891-7. PubMed ID: 17086933
[TBL] [Abstract][Full Text] [Related]
18. Acute mitochondrial actions of glitazones on the liver: a crucial parameter for their antidiabetic properties.
Sanz MN; Sánchez-Martín C; Detaille D; Vial G; Rigoulet M; El-Mir MY; Rodríguez-Villanueva G
Cell Physiol Biochem; 2011; 28(5):899-910. PubMed ID: 22178942
[TBL] [Abstract][Full Text] [Related]
19. Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1alpha gene transcription: an autoregulatory loop controls PGC-1alpha expression in adipocytes via peroxisome proliferator-activated receptor-gamma coactivation.
Hondares E; Mora O; Yubero P; Rodriguez de la Concepción M; Iglesias R; Giralt M; Villarroya F
Endocrinology; 2006 Jun; 147(6):2829-38. PubMed ID: 16513826
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of benzoxazole containing thiazolidinedione derivatives.
Jeon R; Park S
Arch Pharm Res; 2004 Nov; 27(11):1099-105. PubMed ID: 15595409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
